Isthmus Partners, LLC Abbott Laboratories Transaction History

Isthmus Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $36,631 - $40,524	-314 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $33,218 - $39,102	314 New	314 $36,000
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $8.92 Million - $10.4 Million	-122,361 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$66.22 - $80.06 $170,847 - $206,554	-2,580 Reduced 2.06%	122,361 $9.78 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $58,610 - $66,397	894 Added 0.72%	124,941 $9.04 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $292,496 - $352,861	-4,810 Reduced 3.73%	124,047 $9.1 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $95,566 - $105,476	-1,660 Reduced 1.27%	128,857 $7.86 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $371,382 - $419,892	-6,600 Reduced 4.81%	130,517 $7.82 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $128,993 - $138,100	-2,403 Reduced 1.72%	137,117 $7.83 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $6.71 Million - $7.48 Million	139,520	139,520 $7.45 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Isthmus Partners, LLC with notifications on news.